Table 1.
Names | Sequences |
---|---|
Group 1 | |
606 | 5′-AGTTAAAGCAGAACTGCGT-3′ |
741 | 5′-CAGAGGGTATCTTCTGGAC-3′ |
swk2s | 5′-GTAGAGTTGGTTGCTATAGT-3′ |
mo4a | 5′-TTAGGATC CTCTTGTAAGACTCCCTAAT-3′ |
Group 2 | |
ror2s | 5′-AGACGCGGATCC TCGTATGTTGTGCCTGATCT-3′ |
ror2a | 5′-CCGCTAGAATTCTTA TGTAGCAGGTTCTGA TGACT-3′ |
ro2is | 5′-ATTCGAGGATCC AAACGGATTGGTTATATATG-3′ |
ro2ia | 5′-GTCTCAGAATTC TTAATTAAAATTTTTCAGAT-3′ |
ror1s | 5′-TAACGCGGATCC GCAAATCTGAAGTCTGAAAA-3′ |
ror1a | 5′-GTTCTAGAATTCTCA CCAGGTTTTGGAAGTGTT-3′ |
ror1a2 | 5′-GTTCTAGAATTCTCA TGGGGG ACCAATCTG-3′ |
ror1va | 5′-GTTCTAGAATTCTCA GAGAAATAGTTTCACTT-3′ |
Group 3 | |
GASs | 5′-GATTTTCCCAGAAAAGGAAC-3′ |
ISREs | 5′-TTTACAAACAGCAGGAAATAGAAACTTAAGAGAAATACA-3′ |
Group 1 was used for RT-PCR detection of ovIFNAR1f and ovIFNAR1e; group 2 was used for preparing recombinant proteins; and group 3 (sense only shown) for EMSA.